{"name":"Cancer Targeted Technology","slug":"cancer-targeted-technology","ticker":"","exchange":"","domain":"","description":"Cancer Targeted Technology is a biotechnology company focused on developing innovative therapies for cancer. The company has two drugs in its pipeline, both currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNeVVKdHd4eTJxeTFyUWU5OXdyRV9jbXE5ZVZZaGRLSXlpdUQ2MFlqVjZwQjFFY3YtanIxZk9wQmhqYTlLM1RrdzVxWU1KVGNVMkQ5RmNnaVhMemlUUE5yMEN4TWdKN3ZfLXpnendQN2VDQjZ6YVJ2ZC1QVkFnRU43WjB3LU8zSk1sYjJaemR3aWtvV2FFRzhLOXlnRGVPZw?oc=5","date":"2026-02-06","type":"pipeline","source":"Memorial Sloan Kettering Cancer Center","summary":"New Technology May Improve Treatment of Deadly Lung and Prostate Cancers - Memorial Sloan Kettering Cancer Center","headline":"New Technology May Improve Treatment of Deadly Lung and Prostate Cancers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxNSFFvQXpJSHdtOGVZZDhTMlE1aGlGZnN3c3hOX1N4OUlHOWpxUVBacUhZQ1ZyblREc0NMR2tobjJFaWdJTE5YTHZFa2t5bldpdmJTN25QNWFMR1ExQWtaVjJOaFF6NVVFLTc2VnlLUHNFTFlZUHhLWUpySWlfS2p2dUcyZ3p0VXcwdkpSN2NmV002UlBHYzNjT2tHb25tYmdTT1BsaGk4OUd0RldJV1hndC1FSW9lb3JxSzlOY3FfUXFabVAyYWtVcFVSYVVpNkc0N1dvdXZvOEN2ck9uVFdvTDhqMjVWOUhHZ3c1Y0F2Q3d5ZW9hd1VmN29n?oc=5","date":"2026-01-13","type":"pipeline","source":"South China Morning Post","summary":"Biotech disruptor pushes cancer-targeting cell and gene therapies beyond boundaries - South China Morning Post","headline":"Biotech disruptor pushes cancer-targeting cell and gene therapies beyond boundaries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQSVJJNENleHJ2cXI3NnpDbnkya1FoUDR1S2tCMS1PWEFQcXhRTW43Y2FVVjNSd3NPV1RxZC0yT2NDXzRIeWxBc0t2T0x3WnNMdjl5NTZ2b3VvTWtrLVkyM0E3ZGxkb0tGX0hyUW9EZDRaeVFpby1VOS02clRoeE1sQ1dVV0c4WkJTUFA3clVyRUtPOFFQbXJKZkZxck5VVUFUX0RHU3Z1X0dCTnBvODJjeGZyQm13aDhyQ0ZTZVpPUUk1TDVsdWhMYnptTlgtdw?oc=5","date":"2026-01-07","type":"deal","source":"Inside Precision Medicine","summary":"Shine On: DISCO Licenses Novel AND-Gated Cancer Target to Amgen - Inside Precision Medicine","headline":"Shine On: DISCO Licenses Novel AND-Gated Cancer Target to Amgen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxPYWtKal9YVFNwbWkxM3ZkdTQ3ZjFna0E1VG45QmIwMlYydTBKRGI5a0lXQmdxMG1oYlllcU1ZUVJVbndSWUwxU3l0WFZVMkRYbERSRlNfdWZTbkVtblFWQkFNbzd4NlFDd2lUTGZXUnR3MnMxbzRld2dtbkEzREgydDhpQzFHU1pXQ3RjZUVyX3VoenVNdE1zSmhhZ3IzSGRnX19fZHNiSTdlclg1WHZ5TDdFbUZxQVp5dTdIMW5TLU9jRjYzcEJXTDk3TEsxWXdwWXE3OTlsZExKNm1wWV9XMHpzNG9lUFVQVjJUenNpNVV6WG1td0hYZkNjTzBvaDlhZEdvUXk3RUdrZw?oc=5","date":"2026-01-07","type":"regulatory","source":"Business Wire","summary":"FDA and EMA Grant Orphan Drug Designation for Curadel’s CPI-008, a Targeted Zwitterionic Imaging Drug for Pancreatic Cancer - Business Wire","headline":"FDA and EMA Grant Orphan Drug Designation for Curadel’s CPI-008, a Targeted Zwitterionic Imaging Drug for Pancreatic Can","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxOSVZBaUtnZTFoZkgtUXJQcWdXSG9BU21USTZ6MG1HcEZpUWFsanhvN3pVTm5uVGpyNl9POXJQSEptcXRnNWE0aDkwcVVTVVVqam1vUEdubUJUT0FJQUlkYmVWUHhIWU1WMklZM0sweVZFaS1qUlYxS3l1MGR1eHRYeGFvMnNnLVZmQnJJeG1jR3NReUVoOVh1NGxLNnRRaGFLNkhoSkR0empLS2UzXzVNWjVnZ2NTSmpQNkNPNTlTcFRySWJxSDdHb0wxdUQ5RlgtQkFvaDFTeVlVRVB3SG1lQlpJMURSYmxKUEpTTjY4VE80OHhfNUtQeFBwbFU0YTNJVlE?oc=5","date":"2026-01-07","type":"deal","source":"globenewswire.com","summary":"DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies - globenewswire.com","headline":"DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNWU1uUGRZSGdPc3pXNTRlZlltUndFQ1JRdnZNYWozbS12RWYxa3RCa0taQ3NJUVZhMGhKa09zOWJpY1N6OENMSGt5VUJEUUxhSmM4R0lQQjNKOGRudy1kM2tKUGQ5Tzc0MHBCQmJzX3IwWTI0eEFLUTY2RWIxZ3hnQVQ1djVmSzg?oc=5","date":"2026-01-07","type":"pipeline","source":"Fierce Biotech","summary":"Amgen dances with Disco in $618M cancer target pact - Fierce Biotech","headline":"Amgen dances with Disco in $618M cancer target pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOUDYyVXhMWDNqbG1WbFZEWnpoVEhlbDZVX2tWWGltTWRnQkMteUdFM3pGV2x6M2xqTTNhdFZuM2NrV3VqbjdQakctUWpGd0NaMWR3amNTR2p5WlpHelFqTnJibl81ZnhOWjVYRVlhZjVxRFZpQWxfa2tGbkRTZ25Zd05KdDhmNnM5cXdfZ0dHM3lsa2FJcEoyMmhMVU1HLS1xaUU0UExRZw?oc=5","date":"2025-12-05","type":"pipeline","source":"Drug Target Review","summary":"RNA that knows where to go: the rise of targeted delivery - Drug Target Review","headline":"RNA that knows where to go: the rise of targeted delivery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE92dklUdUtneWlkZWRUOVB6NlNiaDV3QTY3VkxUdGhvVUZUWlFCVDhKRXVaRkJOOTZuc3FndWdEOGtZY1BqRUx3S3F1VVFJMll1Zks0?oc=5","date":"2025-10-27","type":"pipeline","source":"FirstWord Pharma","summary":"GSK bets £268M on Syndivia's preclinical prostate cancer ADC - FirstWord Pharma","headline":"GSK bets £268M on Syndivia's preclinical prostate cancer ADC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPSU9FajMzZDdrWlNuSUNHNTFBTW1OSkZkM01fTTlPblo5amlZQ2tWTkVzdDdGUXVjTHRQVTZoMEhTRWFma045c3FFZHRiQTBKT0xYNFpzcXRRQW1sTGluRm5lb01iWmZocktVUnVBS3REMlNHS0tZNnUzTF9SRDNDUnAwT3hVdC1yTTVrMWZ3MERLZkh1TGMxckQzcUVRWnhFUTZkRVN3?oc=5","date":"2025-10-27","type":"pipeline","source":"Fierce Biotech","summary":"GSK pens $357M pact with French biotech for preclinical prostate cancer ADC - Fierce Biotech","headline":"GSK pens $357M pact with French biotech for preclinical prostate cancer ADC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxQQ1BHUGtGNXJaMzFIMGl5aDFTakcwVXpEVEQwTHFPS0Q0eGhoTWRjbGR6eERPbTFLenVwR3RGam9SQmtYNnhWbDU2dUNBU0hNTE5nSU1ORGk0S2ZBQ1FtdU1qbUw1eG1LUnF4eG5ZZEpVZG9kdU14VWtYcDlqTDRJei10amFVN3NON2Y0SzE2RDNNNlhzYWQxUkV4TkdFN2pyLUpuTU80SlF6c094Zmd0UVBBb1g2aEZnRFlVZmtZUVpHa0R5cjR4cXgxcmVxMjYzb1J5NFkwWUxZdnNaQUdtZWRrcDZYNDh0Yy1HTExFdzItenRRWXVj?oc=5","date":"2025-09-30","type":"deal","source":"Technology Networks","summary":"N4 Pharma Collaboration With SRI International Demonstrates Nuvec - Technology Networks","headline":"N4 Pharma Collaboration With SRI International Demonstrates Nuvec","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNR0twSHktVk9leUVGV0wyVHBycDh6VjFabXRJQnhQSkNzamJOWjBoSFVmSHltYUpTcXV0dXJ6TEhtVFNhdlNIMGwwYlBmbFFtT1FBX1lkV1VuTWVqQ3ZXMjZKaXJ3V1Y0TXdwMk5kWU0ya0Z3RlNPTUN2MVN4akVSRVgyTFBPdERVN0tBc3B3Wk52MEx1aGZvTU9tVVNOanBwZUtjNDFmVXJ4OG1uT1R4bnd3djFERXB2WVdZ?oc=5","date":"2025-05-26","type":"pipeline","source":"Forbes Australia","summary":"Australian startups take on big pharma with precision cancer breakthroughs - Forbes Australia","headline":"Australian startups take on big pharma with precision cancer breakthroughs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE5pSnRCZ1RhVUZnYkJQZkoyQjVCOXZEUDVDb3JUcThrU3poMkdDTFFqR2wtLWhlMGctek9ucGhtMFUxdnZtYk0tV19sUXliYmpsT0VPRzU5emktU1Z3VWpESjBHcUY5SzlaeUpkd0N5Y1lFelRFYmg0?oc=5","date":"2025-04-25","type":"pipeline","source":"Manufacturing Chemist","summary":"Jazz Pharmaceuticals commercialises enhanced antibody, Ziihera, for biliary tract cancer - Manufacturing Chemist","headline":"Jazz Pharmaceuticals commercialises enhanced antibody, Ziihera, for biliary tract cancer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}